T20/C4 Sativa

Dominate Cannabinoids:

Batch FT080322

THC 18%

The G150 hybrid variety was selected from hundreds of varieties that underwent a unique genetic scan. It boasts a dense and shiny inflorescence and produces a fresh pine and lemon aroma.

Dominant Terpenes

Being spicy and pungent, b-Caryophyllene conveys a pleasant warmth. This terpene is found in various aromatic plants and spices, such as black pepper, basil, oregano, cloves, rosemary, and cinnamon, as well as in popular cannabis strains such as Girl Scout Cookies. b-Caryophyllene is the only terpene that acts within the body like a cannabinoid. It affects the cannabinoid system by binding to CB2 receptors throughout the body, and it likewise has an anti-inflammatory effect.


It is considered the most abundant terpene among the various cannabis strains, which is responsible for a sweet tropical flavor and an earthy aroma with a hint of the mask. Other than that, b-Myrcene is found in hops, thyme, bay leaves, parsley, and basil as well as in cardamom, lemon grass, mango, and Spanish lime fruits. b-Myrcene is considered as having sedative effects, and studies have demonstrated a reduction in stress and anxiety levels while elevating a sense of relaxation and calmness, energy levels, and mood. It likewise demonstrated pain relief and sleep induction potential together with strong antioxidant activity.

Linalool is a terpene that is quite abundant in nature and is found in over 200 types of plants, including lavender, roses, basil, and neroli oil. It has a characteristic lavender-dominant aroma with some gentle hints of pungency. Plants produce linalool as part of their defense mechanism against pests, and this explains linalool’s strong anti-microbial properties and the fact that it is being studied as an anti-bacterial agent. In traditional herbal medicine, it is customary to use medicinal herbs containing linalool for calming and relaxing the body. And indeed, clinical research on lavender essential oil (of which linalool is a major constituent) has demonstrated a calming, stress-reducing effect. Additionally, in a clinical study with patients post gastric band surgery, inhaling linalool vapor had a significant analgesic effect.



a-Humulene is a with an earthy-woody aroma. Its name is derived from the plant Hummulus Lupulus which belongs to the same botanic family as the cannabis plant, and it is likewise found in sage and ginseng roots.  a-Humulene constitutes part of the defense mechanism of the cannabis plant against various pests, due to its strong anti-microbial activity. Preliminary studies demonstrated anti-oxidant, anti-inflammatory, gastro-protective, and appetite suppression potential.


Taste and Aroma




* This information herein does not constitute a binding opinion and should not be relied upon except as a general review, which is not a substitute for a professional medical opinion. CANONIC cannot guarantee and is not responsible that the effects described, or similar effects, will be felt by patients. The information should not be construed as advertisement and / or recommendation and / or encouragement for the use of cannabis, which is a prohibited use by law, other than for medical purposes. The use of medical cannabis is subject to the recommendation of a specialist doctor and in accordance with a suitable license from the Ministry of Health according to law.


Pre-clinical studies have shown:

Canonic’s G150

Has Positive Results In It’s Anti-Inflammatory And Pain Relief Properties.

In pre-clinical studies reported on January 2022, Canonic screened multiple cannabis varieties from its diverse genetic collection for anti-inflammatory and pain relief properties. The varieties had been selected based on their active compounds compositions using Evogene’s GeneRator AI tech engine. The screening of the selected varieties was conducted in two separate models – in an in-vitro model at the laboratory of Prof. Reuven Or at the Hadassah Medical Center and in an in-vivo (fish larvae) model at Migal – Galilee Research Institute. Several varieties, including the cannabis variety which is the basis for Canonic’s product G150, exhibited consistent positive results in both model systems, over several repetitions and independent cultivation cycles.

Based on these results, Canonic has filed a patent application for several of these cannabis varieties and their medical effects.


“We would all like to think that cannabis represents a potential solution for specific, difficult to treat, medical conditions, such as pain or inflammatory diseases, for which we lack ideal treatments. After all, it would be poetic if nature’s wisdom provided the medicine we have not yet designed ourselves. The ability of Canonic’s medical cannabis varieties in reducing pain and inflammation in pre-clinical settings is impressive. Indeed, breeding whole cannabis plants such that they contain specific compounds in specific quantities and tailored ratios in order to hit the right disease targets with minimal adverse events is what we should aim for in order to benefit our society. And this is exactly what Canonic does.”

Prof. Yosi Tom

Managing Director of the Multidisciplinary Center for Cannabinoid Research at the Hebrew University of Jerusalem & Advisor to Canonic


The effect of G150, as measured in preclinical trials, is presented for reducing inflammation levels compared to the control- ‘no treatment’ and to synthetic CBD (the effect is explained as % of the control).


The effect of G150, as measured in preclinical trials, is presented for reducing pain levels compared to the control- ‘no treatment’ and to a commercial pain killer (the effect is explained as % of the control).

* The studies were conducted under laboratory and live model conditions in fish, and did not include a clinical trial in humans.

** The above is provided as an informational overview, Canonic does not provide any guaranties regarding the described effects, which may vary among patients.

***The foregoing should not be construed as advertising and/or a recommendation and/or encouragement to use cannabis for non-medical purposes, which is prohibited by law. The use of medical cannabis is at the recommendation of a specialist and according to an appropriate license from the Ministry of Health in accordance with the law.


Together With You

You can help us develop better products! Canonic invites you to share with us experiences from the treatment. Combined with our extensive genetic databases, your feedback can help create strains that are better suited to patients’ needs. Join us, and together we will improve the therapeutic experience.

More Products


Two Aces

T20/C4 Sativa


T20/C4 Sativa

Two Stars

T20/C4 Indica

Blend Kush

T20/C4 Indica


T20/C4 Indica

Mash Kush

T20/C4 Indica


T20/C4 Indica



T20/C4 Sativa

G150 OIL

T20/C4 Sativa

G200 OIL

T20/C4 Indica